R10-2023-e No-cost extension for COVID-19 Output in the project entitled “Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs”

R9-2023-e Additional ACT-A investments to accelerate and expand Unitaid’s support for the development and introduction of molecular diagnostics

R8-2023-e Extension of authorization to procure COVID-19 therapeutics, with reallocation of unspent ACT-A funds to Unitaid’s Medical Oxygen Portfolio

R14-2023-e Cost Extension for the Project “Broad One Health Endectocide-based Malaria Intervention in Africa” (BOHEMIA)

R13-2023-e Extension for the Project “Rapid, comprehensive targeted gene sequencing solution for drug-resistant TB diagnosis in LMICs”

R7-2023-e Governance Working Group Appointment of members

R5-2023-e Cost Extension for the Project ‘Preventing deaths from cervical cancer by catalysing the use of optimal screening tests and treatment devices’

R4-2023-e Go-ahead for the development of grant agreement packages on Preventing deaths among adults and children by simplifying Advanced HIV Disease management for proposed projects with Clinton Health Access Initiative (CHAI) and The Aurum Institute